C
4.62
0.15 (3.36%)
| Penutupan Terdahulu | 4.47 |
| Buka | 4.48 |
| Jumlah Dagangan | 727,593 |
| Purata Dagangan (3B) | 779,549 |
| Modal Pasaran | 253,630,160 |
| Harga / Jualan (P/S) | 436.42 |
| Harga / Buku (P/B) | 3.44 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 13 Nov 2025 |
| EPS Cair (TTM) | -1.33 |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 14.61% |
| Nisbah Semasa (MRQ) | 4.64 |
| Aliran Tunai Operasi (OCF TTM) | -27.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | -8.33 M |
| Pulangan Atas Aset (ROA TTM) | -32.31% |
| Pulangan Atas Ekuiti (ROE TTM) | -98.14% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Biotechnology (US) | Bercampur | Bercampur |
| Biotechnology (Global) | Bercampur | Bercampur | |
| Stok | Candel Therapeutics, Inc. | Menaik | Menurun |
AISkor Stockmoo
1.5
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | NA |
| Volatiliti Harga | 0.5 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | -2.0 |
| Purata | 1.50 |
|
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively. |
|
| Sektor | Healthcare |
| Industri | Biotechnology |
| Gaya Pelaburan | Small Growth |
| % Dimiliki oleh Orang Dalam | 17.53% |
| % Dimiliki oleh Institusi | 40.72% |
Pemilikan
| Nama | Tarikh | Syer Dipegang |
|---|---|---|
| Sands Capital Alternatives, Llc | 30 Sep 2025 | 405,837 |
| Tanager Wealth Management Llp | 30 Sep 2025 | 198,175 |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 24.00 (Citigroup, 419.48%) | Beli |
| Median | 19.50 (322.08%) | |
| Rendah | 15.00 (Stephens & Co., 224.68%) | Beli |
| Purata | 19.50 (322.08%) | |
| Jumlah | 4 Beli | |
| Harga Purata @ Panggilan | 5.28 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| Citigroup | 14 Nov 2025 | 24.00 (419.48%) | Beli | 4.64 |
| Stephens & Co. | 28 Oct 2025 | 15.00 (224.68%) | Beli | 5.60 |
| LifeSci Capital | 21 Oct 2025 | 16.00 (246.32%) | Beli | 5.49 |
| HC Wainwright & Co. | 29 Sep 2025 | 23.00 (397.84%) | Beli | 5.40 |
Tiada data dalam julat masa ini.
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2025 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |